Methods and compositions for inhibition of treg cells
作者： Michael Har-Noy
DOI:
关键词:
摘要: The present invention relates to methods of suppressing the immune tolerance a disease or antigens in patient. method also promotes activity effectore T lymphocytes. includes administering therapeutic composition that Th1 environment patient while decreasing immunosuppressive Treg cells can lead antigen and immunoavoidance by allogeneic emTh-1 cells. include such as chaperone-rich cell lysate antigen.
lens.org参考文章(9)
Michael W. Graner, Yi Zeng, Hanping Feng, Emmanuel Katsanis, Tumor-derived chaperone-rich cell lysates are effective therapeutic vaccines against a variety of cancers. Cancer Immunology, Immunotherapy. ,vol. 52, pp. 226- 234 ,(2003) , 10.1007/S00262-002-0359-2
Michael Har-Noy, Th1 vaccination priming for active immunotheraphy ,(2009)
Michael Har-Noy, Methods and compositions for liquidation of tumors ,(2010)
Michael Har-Noy, Allogeneic cell therapy: mirror effect ,(2004)
Michael L. Gruenberg, Surendra Chavan, Th1 CELL ADOPTIVE IMMUNOTHERAPY ,(2002)
M. Har-Noy, M. Zeira, L. Weiss, E. Fingerut, R. Or, S. Slavin, Allogeneic CD3/CD28 cross-linked Th1 memory cells provide potent adjuvant effects for active immunotherapy of leukemia/lymphoma. Leukemia Research. ,vol. 33, pp. 525- 538 ,(2009) , 10.1016/J.LEUKRES.2008.08.017
N. Larmonier, J. Cantrell, C. LaCasse, G. Li, N. Janikashvili, E. Situ, M. Sepassi, S. Andreansky, E. Katsanis, Chaperone‐rich tumor cell lysate‐mediated activation of antigen‐presenting cells resists regulatory T cell suppression Journal of Leukocyte Biology. ,vol. 83, pp. 1049- 1059 ,(2008) , 10.1189/JLB.0907635
Haruo Sugiyama, Novel method of inducing antigen-specific t cells ,(2002)
Michael Har-Noy, Vaccine compositions and methods ,(2009)